{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:10:51Z","timestamp":1793437851320,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jcmg.2025.01.018","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T14:09:03Z","timestamp":1748441343000},"page":"799-811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography\/Computed Tomography"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5497-8866","authenticated-orcid":false,"given":"Dia A.","family":"Smiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-9278","authenticated-orcid":false,"given":"Andrew J.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"O\u2019Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5615-7328","authenticated-orcid":false,"given":"Ani","family":"Nalbandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Poterucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Helmke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiva","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Goldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Sekulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonsina","family":"Mirabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret O.","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Guadalupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffeny","family":"De Los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Paulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massiel","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdirahman","family":"Wardhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Bampatsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcmg.2025.01.018_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jcmg.2025.01.018_bib2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcmg.2025.01.018_bib3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jcmg.2016.06.003","article-title":"Can 99mTc-pyrophosphate aid in early detection of cardiac involvement in asymptomatic variant TTR amyloidosis?","volume":"10","author":"Haq","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.jcmg.2025.01.018_bib4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cardfail.2024.02.014","article-title":"Temporal outcomes of patients diagnosed with transthyretin cardiac amyloidosis","volume":"30","author":"Chan","year":"2024","journal-title":"J Card Fail"},{"issue":"24","key":"10.1016\/j.jcmg.2025.01.018_bib5","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.jcmg.2025.01.018_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.121.055517","article-title":"Cardiac scintigraphy and screening for transthyretin cardiac amyloidosis: caveat emptor","volume":"144","author":"Maurer","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jcmg.2025.01.018_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.jcmg.2025.01.018_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.015243","article-title":"Gene silencing therapy in hereditary (variant) transthyretin cardiac amyloidosis: a puzzling case of decreasing pyrophosphate uptake on scintigraphy","volume":"16","author":"Smiley","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.jcmg.2025.01.018_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.jcmg.2025.01.018_bib10","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.jcmg.2025.01.018_bib11","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.jcmg.2025.01.018_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann Nucl Med"},{"issue":"34","key":"10.1016\/j.jcmg.2025.01.018_bib13","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1073\/pnas.1103247108","article-title":"In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides","volume":"108","author":"Wall","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jcmg.2025.01.018_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/13506120601116419","article-title":"Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications","volume":"14","author":"Kisilevsky","year":"2007","journal-title":"Amyloid"},{"issue":"42","key":"10.1016\/j.jcmg.2025.01.018_bib15","doi-asserted-by":"crossref","first-page":"26091","DOI":"10.1074\/jbc.272.42.26091","article-title":"Amyloid-specific heparan sulfate from human liver and spleen","volume":"272","author":"Lindahl","year":"1997","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.jcmg.2025.01.018_bib16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.0300-9475.2004.01516.x","article-title":"Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice","volume":"60","author":"Sugumaran","year":"2004","journal-title":"Scand J Immunol"},{"issue":"52","key":"10.1016\/j.jcmg.2025.01.018_bib17","doi-asserted-by":"crossref","first-page":"41143","DOI":"10.1074\/jbc.M110.153791","article-title":"The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease","volume":"285","author":"Smits","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.jcmg.2025.01.018_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using 124I-evuzamitide (124I-P5+14) versus 18F-florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10.1016\/j.jcmg.2025.01.018_bib19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine (124I) evuzamitide (124I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.jcmg.2025.01.018_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11307-021-01681-2","article-title":"First in human evaluation and dosimetry calculations for peptide 124I-p5+14\u2014a novel radiotracer for the detection of systemic amyloidosis using PET\/CT imaging","volume":"24","author":"Wall","year":"2022","journal-title":"Mol Imaging Biol"},{"issue":"5","key":"10.1016\/j.jcmg.2025.01.018_bib21","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3390\/molecules20057657","article-title":"Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis","volume":"20","author":"Wall","year":"2015","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jcmg.2025.01.018_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/14653125221076142","article-title":"On correlation coefficients and their interpretation","volume":"49","author":"Papageorgiou","year":"2022","journal-title":"J Orthod"},{"issue":"3","key":"10.1016\/j.jcmg.2025.01.018_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaccao.2020.06.007","article-title":"Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis","volume":"2","author":"Cheng","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"2 Pt A","key":"10.1016\/j.jcmg.2025.01.018_bib24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cjco.2023.11.017","article-title":"False negative 99mTc-DPD scintigraphy in pVal50Met (Val30Met) hereditary transthyretin amyloidosis","volume":"6","author":"Redzepi","year":"2024","journal-title":"CJC Open"},{"issue":"6","key":"10.1016\/j.jcmg.2025.01.018_bib25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jcmg.2019.10.015","article-title":"Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis","volume":"13","author":"Musumeci","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.jcmg.2025.01.018_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in Black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcmg.2025.01.018_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly Black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jcmg.2025.01.018_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028973","article-title":"Clinical penetrance of the transthyretin V122I variant in older Black patients with heart failure: the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) study","volume":"12","author":"Madhani","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jcmg.2025.01.018_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.nmd.2018.11.002","article-title":"6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR)","volume":"29","author":"Vita","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.jcmg.2025.01.018_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.jcmg.2025.01.018_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp2111320","article-title":"Controversy and progress in Alzheimer\u2019s disease\u2014FDA approval of aducanumab","volume":"385","author":"Rabinovici","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jcmg.2025.01.018_bib32","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jaccao.2022.07.007","article-title":"Prognosis of transthyretin cardiac amyloidosis without heart failure symptoms","volume":"4","author":"Gonzalez-Lopez","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"4","key":"10.1016\/j.jcmg.2025.01.018_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301756","article-title":"Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis","volume":"19","author":"Kennel","year":"2024","journal-title":"PLoS One"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X25001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X25001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:10:11Z","timestamp":1782954611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X25001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1936878X25001767"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2025.01.018","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2025.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}